Appendix cancer has no single known cause, but a combination of genetic mutations, lifestyle factors, and possibly chronic changes in stomach acid appear to play a role. It is extremely rare, affecting roughly 1 to 2 people per million each year in the United States. Because so few cases occur, pinpointing exact causes has been difficult, but researchers have identified several factors that increase risk or drive tumor growth once it begins.
Types of Appendix Cancer and Why They Matter
Not all appendix cancers are the same, and the type you have influences what likely triggered it at the cellular level. The World Health Organization recognizes several distinct categories based on the kind of cell the tumor originates from.
Mucinous neoplasms are the most distinctive group. These range from slow-growing, low-grade tumors confined to the inner lining of the appendix to aggressive mucinous adenocarcinomas that invade deeper tissue and can spread mucin-producing cells into the abdominal cavity, a condition called pseudomyxoma peritonei. A tumor is classified as mucinous when more than half of it consists of mucin, a gel-like substance.
Adenocarcinomas that don’t produce mucin resemble colon cancer under a microscope but behave differently at the molecular level. Signet ring cell adenocarcinoma, where more than half the tumor is made up of a specific type of cell with a ring-like shape, tends to be more aggressive. Goblet cell adenocarcinoma is a hybrid that shares features with both glandular cancers and neuroendocrine tumors. Neuroendocrine tumors, which arise from hormone-producing cells, make up their own separate category and are often discovered incidentally during an appendectomy for suspected appendicitis.
Genetic Mutations Behind Tumor Growth
A major study published by the National Cancer Institute found that appendix cancers are genetically distinct from colorectal cancers, even though the two organs are neighbors in the digestive tract. This matters because treatments designed for colon cancer don’t necessarily work for appendix cancer.
Mutations in the KRAS gene are common in appendiceal adenocarcinomas but much less frequent in goblet cell tumors. KRAS helps regulate cell growth, and when it’s mutated, cells can multiply without the normal stop signals. Mutations in a gene called GNAS also appear frequently, particularly in slower-growing, low-grade tumors. GNAS mutations were almost never found in high-grade, fast-spreading cancers, which suggests they may be linked to a less aggressive disease course.
On the other end of the spectrum, mutations in the TP53 gene were tied to worse outcomes regardless of tumor grade. TP53 normally acts as a brake on cell division, so when it stops working, tumors tend to grow and spread more readily. Notably, both TP53 and APC (another tumor-suppressor gene that drives most colorectal cancers) were far less likely to be mutated in appendix cancer than in colon cancer. A small proportion of appendiceal tumors also showed a pattern called microsatellite instability, where the cell’s DNA repair machinery breaks down and mutations accumulate rapidly.
Precursor Lesions and How Tumors Progress
Some appendix cancers don’t appear out of nowhere. They develop from precursor growths, much like colon polyps can eventually become colon cancer. Mucinous adenomas and low-grade appendiceal mucinous neoplasms (LAMNs) are confined to the inner lining of the appendix and are considered the earliest stage on this spectrum. Over time, some of these lesions acquire additional mutations and progress to high-grade mucinous adenocarcinomas that invade through the appendix wall. Serrated lesions and conventional adenomas can also serve as starting points. Because the appendix is small and these growths rarely cause symptoms early on, they’re often found only after a person develops appendicitis or undergoes imaging for an unrelated reason.
Smoking and Lifestyle Factors
Smoking is a recognized risk factor for appendix cancer. The carcinogens in tobacco reach the digestive tract and can damage cells lining the appendix, just as they damage cells elsewhere in the body.
Chronically low stomach acid may also be involved. Conditions like atrophic gastritis, pernicious anemia, and long-term Helicobacter pylori infection reduce acid production in the stomach. Some research suggests that long-term use of acid-suppressing medications, including proton pump inhibitors and H2 receptor blockers, could be associated with gastrointestinal cancers including appendiceal cancer, though evidence on this point remains inconclusive. The theory is that reduced stomach acid changes the chemical environment of the gut in ways that may promote abnormal cell growth.
General cancer-prevention strategies still apply: a nutritious diet, regular physical activity, and limiting alcohol consumption all contribute to lower overall cancer risk.
Age, Gender, and Demographics
Appendix cancer is most commonly diagnosed in people over 50. In a large English population study of more than 7,000 cases, 65% of patients were older than 50 at diagnosis. Women made up a slight majority at nearly 57% of cases, though the rate of increase over time has been similar for both sexes.
Incidence has been rising across all age groups, with the sharpest percentage increases occurring in younger adults. People in their 20s and 30s saw the fastest growth rates in new diagnoses, though the absolute numbers remain small. The reasons for this trend aren’t fully understood and may partly reflect better detection through improved imaging and pathology rather than a true biological increase.
The Link Between Appendicitis and Cancer
A large population-based study published in The Lancet found that people treated for acute appendicitis had a significantly higher chance of being diagnosed with colon cancer in the months that followed, particularly right-sided colon cancer. During the first six months after appendicitis, the risk of a colon cancer diagnosis was roughly eight times higher than in people who never had appendicitis.
This doesn’t mean appendicitis causes cancer. The researchers concluded the relationship is likely reverse causality: an existing tumor triggers the inflammation and blockage that leads to appendicitis, rather than the other way around. In other words, appendicitis can be the first visible sign that a cancer is already present. This is one reason surgeons routinely send removed appendix tissue to pathology for examination, even when appendicitis seems straightforward.
How Appendix Cancer Differs From Colon Cancer
Because the appendix is part of the large intestine, it’s natural to assume its cancers would behave like colorectal cancer. They don’t. Molecular profiling comparing appendiceal adenocarcinoma with both right-sided and left-sided colon cancers found distinct genetic patterns in each. Appendix tumors are more likely to spread by seeding the lining of the abdominal cavity with mucin-producing cells rather than traveling through the bloodstream to distant organs like the liver or lungs, which is the more typical route for colon cancer.
The immune profile of appendix cancer turned out to resemble left-sided colon cancer more than right-sided, which was unexpected given the appendix’s location on the right side of the body. Different histological subtypes of appendix cancer also varied in how likely they were to express markers that respond to immunotherapy, with non-mucinous tumors showing the highest rates at about 11% and mucinous subtypes showing much lower rates. These differences reinforce why appendix cancer needs its own treatment approach rather than being treated as a variant of colon cancer.